3 Canadian Jr Pharma Plays Just Repurposed their existing Drugs to the Covid-19

+ RVV Riased enough $1.6M Recently to get the Ball Rolling

https://stockcharts.com/freecharts/candleglance.html?lbl.v,agn.ca,rvv.ca|B|0

AGN - 90M S/O March 13th $18M Mcap
ALGERNON ANNOUNCES FILING OF U.S. FDA PRE-IND MEETING REQUEST FOR IFENPRODIL CORONAVIRUS TRIAL, EXPANDED ACCESS, AND EMERGENCY USE

LBL - 93 M S/O March 13th  $10.2M Mcap
LATTICE BIOLOGICS TO EVALUATE ANTI-INFLAMMATORY STEM CELL OMNIOBOOST THERAPY TREATMENT OF COVID-19 LUNG DISEASE

RVV - 72 M S/O March 20th $4.6M MCap
REVIVE THERAPEUTICS EXPLORES THE USE OF BUCILLAMINE AS A NOVEL TREATMENT FOR INFECTIOUS DISEASES INCLUDING COVID-19